RE: Much in the pipeline and negotiations with ‘famous’ names are ongoing for Hemogenyx Pharmaceuticals20 Jul 2021 10:22
Good line of questioning from Sarah Lowther
Trying to link the science back to how it effects share holders.
Enough capital for a minimum of 12m, likely more.
CAR T first to trial. Manufacturing processes has begun. IND app can’t be too far away now… by end of summer imo?
CDX negotiations continue, other parties interested on top of GlobalCo.
Plenty going on.